Literature DB >> 20729813

Co-occurrence of Langerhans cell histiocytosis and Rosai-Dorfman disease: possible relationship of two histiocytic disorders in rare cases.

Dennis P O'Malley1, Angie Duong, Todd S Barry, Steve Chen, Michele K Hibbard, Judith A Ferry, Robert P Hasserjian, Mary A Thompson, Mary S Richardson, Ronald Jaffe, Jagmohan S Sidhu, Peter M Banks.   

Abstract

Rosai-Dorfman disease and Langerhans cell histiocytosis are both disorders of accessory immune cells. Two cases have been previously reported of concurrent Langerhans cell histiocytosis and Rosai-Dorfman disease. In this report, we characterize the findings and selected molecular studies in nine additional cases. Histology was reviewed. Immunohistochemical stains were performed on all cases in which slides or blocks were available. A combination of CD1a, S-100, CD3, CD20, langerin, CD68, CD163, CD21, CD35 and CD123 immunohistochemical stains were performed. High-resolution array comparative genomic hybridization was performed on six samples from five cases. In these cases, seven were female and two male, with an average age of 25 years (15 months-59 years). A majority of the cases were identified in lymph node. Areas of Langerhans cell histiocytosis had a typical appearance with the existence of bland 'coffee-bean' nuclei, clear cytoplasm and associated eosinophils. The immunophenotype was typical, including expression of CD1a, S100, CD68 and langerin. In areas of Rosai-Dorfman disease, there was emperipolesis seen in all cases. Cells were intermediate-large in size with large round nuclei and ample clear or pale cytoplasm. The lesional cells were positive for S100, CD68, CD163, without expression of langerin or CD1a. Array comparative genomic hybridization showed gains and/or losses in four of the six samples. One case showed no gains or losses and one additional case showed gains and losses in the Langerhans cell histiocytosis, while no abnormalities were discovered in the Rosai-Dorfman disease component. These findings are comparable to those seen in previous studies of Langerhans cell histiocytosis. We report the clinical and pathologic findings of the combination of Langerhans cell histiocytosis and Rosai-Dorfman disease. Furthermore, we suggest on the basis of evidence from our cases that, when simultaneous, the two entities may be pathophysiologically related.

Entities:  

Mesh:

Year:  2010        PMID: 20729813     DOI: 10.1038/modpathol.2010.157

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  20 in total

1.  BRAF-V600E-mutated Rosai-Dorfman-Destombes disease and Langerhans cell histiocytosis with response to BRAF inhibitor.

Authors:  Rosemarie Mastropolo; Allison Close; Steven W Allen; Kenneth L McClain; Scott Maurer; Jennifer Picarsic
Journal:  Blood Adv       Date:  2019-06-25

2.  Generalized eruptive histiocytomas and rosai-dorfman disease presenting concurrently in a patient with myelodysplastic syndrome.

Authors:  Benjamin Kaffenberger; Kamruz Darabi; Sara Peters; Sara Peters; Jessica Kynyk; Mark Bechtel
Journal:  J Clin Aesthet Dermatol       Date:  2012-08

Review 3.  Systemic Histiocytosis (Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Destombes-Rosai-Dorfman Disease): from Oncogenic Mutations to Inflammatory Disorders.

Authors:  Matthias Papo; Fleur Cohen-Aubart; Ludovic Trefond; Adeline Bauvois; Zahir Amoura; Jean-François Emile; Julien Haroche
Journal:  Curr Oncol Rep       Date:  2019-05-21       Impact factor: 5.075

4.  Rosai-Dorfman Disease Harboring an Activating KRAS K117N Missense Mutation.

Authors:  Vignesh Shanmugam; Elizabeth Margolskee; Michael Kluk; Tamara Giorgadze; Attilio Orazi
Journal:  Head Neck Pathol       Date:  2016-02-27

Review 5.  Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease.

Authors:  Oussama Abla; Eric Jacobsen; Jennifer Picarsic; Zdenka Krenova; Ronald Jaffe; Jean-Francois Emile; Benjamin H Durham; Jorge Braier; Frédéric Charlotte; Jean Donadieu; Fleur Cohen-Aubart; Carlos Rodriguez-Galindo; Carl Allen; James A Whitlock; Sheila Weitzman; Kenneth L McClain; Julien Haroche; Eli L Diamond
Journal:  Blood       Date:  2018-05-02       Impact factor: 22.113

6.  Rosai-Dorfman Disease: A Rare Clinicopathological Presentation and Review of the Literature.

Authors:  Aileen Azari-Yaam; Mohammad Reza Abdolsalehi; Mohammad Vasei; Moeinadin Safavi; Mehrzad Mehdizadeh
Journal:  Head Neck Pathol       Date:  2020-06-05

7.  Atypical Case of Rosai-Dorfman Disease of the Lacrimal Gland with Adjacent Bone Erosion.

Authors:  Mohammad Dahrouj; Frederick A Jakobiec; Natalie Wolkow; Victoria S Starks; Nahyoung Grace Lee
Journal:  Ocul Oncol Pathol       Date:  2018-07-18

8.  A case of coexisting Warthin tumor and langerhans cell histiocytosis associated with necrosis, eosinophilic abscesses and a granulomatous reaction in intraparotid lymph nodes.

Authors:  Char Loo Tan; Gangaraju Changal Raju; Fredrik Petersson
Journal:  Rare Tumors       Date:  2011-04-04

9.  Rosai-Dorfman disease mimicking images of meningiomas: Two case reports and literature review.

Authors:  Rafael Trindade Tatit; Paulo Eduardo Albuquerque Zito Raffa; Giovana Cassia de Almeida Motta; André Alexandre Bocchi; Júlia Loripe Guimaraes; Paulo Roberto Franceschini; Paulo Henrique Pires de Aguiar
Journal:  Surg Neurol Int       Date:  2021-06-21

10.  Rosai-Dorfman disease: a report of eight cases in a tertiary care center and a review of the literature.

Authors:  R C Maia; E de Meis; S Romano; J A Dobbin; C E Klumb
Journal:  Braz J Med Biol Res       Date:  2014-10-10       Impact factor: 2.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.